Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 13.16 NOK -2.52%
Market Cap: 684.8m NOK
Have any thoughts about
Arcticzymes Technologies ASA?
Write Note

Arcticzymes Technologies ASA
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcticzymes Technologies ASA
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Arcticzymes Technologies ASA
OSE:AZT
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Other Income
-kr8.7m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
B
Bergenbio ASA
OSE:BGBIO
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Total Other Income
-kr54k
CAGR 3-Years
45%
CAGR 5-Years
36%
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Other Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Arcticzymes Technologies ASA
Glance View

Market Cap
672.1m NOK
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

AZT Intrinsic Value
21.99 NOK
Undervaluation 40%
Intrinsic Value
Price

See Also

Back to Top